Literature DB >> 19052081

Peripheral NKT cells in simian immunodeficiency virus-infected macaques.

Caroline S Fernandez1, Angela C Chan, Konstantinos Kyparissoudis, Robert De Rose, Dale I Godfrey, Stephen J Kent.   

Abstract

NKT cells are a specialized population of T lymphocytes that have an increasingly recognized role in immunoregulation, including controlling the response to viral infections. The characteristics of NKT cells in the peripheral blood of macaques during simian immunodeficiency virus (SIV) or chimeric simian/human immunodeficiency virus (HIV) (SHIV) infection were assessed. NKT cells comprised a mean of 0.19% of peripheral blood lymphocytes across the 64 uninfected macaques studied. Although the range in the percentages of NKT cells was large (0 to 2.2%), levels were stable over time within individual macaques without SIV/SHIV infection. The majority of NKT cells in macaques were CD4(+) (on average 67%) with smaller populations being CD8(+) (21%) and CD4/CD8 double positive (13%). A precipitous decline in CD4(+) NKT cells occurred in all six macaques infected with CXCR4-tropic SHIV(mn229) early after infection, with a concomitant rise in CD8(+) NKT cells in some animals. The depletion of CD4(+) NKT cells was tightly correlated with the depletion of total CD4(+) T cells. R5-tropic SIV(mac251) infection of macaques resulted in a slower and more variable decline in CD4(+) NKT cells, with animals that were able to control SIV virus levels maintaining higher levels of CD4(+) NKT cells. An inverse correlation between the depletion of total and CD4(+) NKT cells and SIV viral load during chronic infection was observed. Our results demonstrate the infection-driven depletion of peripheral CD4(+) NKT cells during both SHIV and SIV infection of macaques. Further studies of the implications of the loss of NKT cell subsets in the pathogenesis of HIV disease are needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052081      PMCID: PMC2643790          DOI: 10.1128/JVI.02138-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  The biology of NKT cells.

Authors:  Albert Bendelac; Paul B Savage; Luc Teyton
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 2.  Current concepts in AIDS pathogenesis: insights from the SIV/macaque model.

Authors:  Andrew A Lackner; Ronald S Veazey
Journal:  Annu Rev Med       Date:  2007       Impact factor: 13.739

3.  Cutting edge: Rapid recovery of NKT cells upon institution of highly active antiretroviral therapy for HIV-1 infection.

Authors:  Hans J J van der Vliet; Marit G A van Vonderen; Johan W Molling; Hetty J Bontkes; Martine Reijm; Peter Reiss; Michiel A van Agtmael; Sven A Danner; Alfons J M van den Eertwegh; B Mary E von Blomberg; Rik J Scheper
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

4.  Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes.

Authors:  Miranda Z Smith; C Jane Dale; Robert De Rose; Ivan Stratov; Caroline S Fernandez; Andrew G Brooks; Jason Weinfurter; Kendall Krebs; Cara Riek; David I Watkins; David H O'connor; Stephen J Kent
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model.

Authors:  C Jane Batten; Robert De Rose; Kim M Wilson; Michael B Agy; Socheata Chea; Ivan Stratov; David C Montefiori; Stephen J Kent
Journal:  AIDS Res Hum Retroviruses       Date:  2006-06       Impact factor: 2.205

6.  Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples.

Authors:  Stuart P Berzins; Andrew D Cochrane; Daniel G Pellicci; Mark J Smyth; Dale I Godfrey
Journal:  Eur J Immunol       Date:  2005-05       Impact factor: 5.532

7.  Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.

Authors:  Robert De Rose; C Jane Batten; Miranda Z Smith; Caroline S Fernandez; Viv Peut; Scott Thomson; Ian A Ramshaw; Barbara E H Coupar; David B Boyle; Vanessa Venturi; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

8.  IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production.

Authors:  Jonathan M Coquet; Konstantinos Kyparissoudis; Daniel G Pellicci; Gurdyal Besra; Stuart P Berzins; Mark J Smyth; Dale I Godfrey
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

9.  Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.

Authors:  David H Chang; Keren Osman; John Connolly; Anjli Kukreja; Joseph Krasovsky; Maggi Pack; Aisha Hutchinson; Matthew Geller; Nancy Liu; Rebecca Annable; Jennifer Shay; Kelly Kirchhoff; Nobusuke Nishi; Yoshitaka Ando; Kunihiko Hayashi; Hani Hassoun; Ralph M Steinman; Madhav V Dhodapkar
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

10.  Differential antitumor immunity mediated by NKT cell subsets in vivo.

Authors:  Nadine Y Crowe; Jonathan M Coquet; Stuart P Berzins; Konstantinos Kyparissoudis; Rachael Keating; Daniel G Pellicci; Yoshihiro Hayakawa; Dale I Godfrey; Mark J Smyth
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

View more
  20 in total

1.  In-vivo stimulation of macaque natural killer T cells with α-galactosylceramide.

Authors:  C S Fernandez; S Jegaskanda; D I Godfrey; S J Kent
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

2.  Heterogeneity in phenotype and function of CD8+ and CD4/CD8 double-negative Natural Killer T cell subsets in sooty mangabeys.

Authors:  Namita Rout; James G Else; Simon Yue; Michelle Connole; Mark A Exley; Amitinder Kaur
Journal:  J Med Primatol       Date:  2010-08       Impact factor: 0.667

3.  Immune activation in the pathogenesis of treated chronic HIV disease: a workshop summary.

Authors:  Susan F Plaeger; Brenda S Collins; Runa Musib; Steven G Deeks; Sarah Read; Alan Embry
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-27       Impact factor: 2.205

4.  T cell functionality in HIV-1, HIV-2 and dually infected individuals: correlates of disease progression and immune restoration.

Authors:  S Salwe; V Padwal; V Nagar; P Patil; V Patel
Journal:  Clin Exp Immunol       Date:  2019-07-18       Impact factor: 4.330

5.  Impairment of CD1d-restricted natural killer T cells in chronic HIV type 1 clade C infection.

Authors:  Marianne W Mureithi; Kristen Cohen; Ramona Moodley; Danielle Poole; Zenele Mncube; Anne Kasmar; D Branch Moody; Philip J R Goulder; Bruce D Walker; Marcus Altfeld; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-13       Impact factor: 2.205

Review 6.  A double-edged sword: the role of NKT cells in malaria and HIV infection and immunity.

Authors:  Sandhya Vasan; Moriya Tsuji
Journal:  Semin Immunol       Date:  2009-12-04       Impact factor: 11.130

7.  Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection.

Authors:  Namita Rout; James G Else; Simon Yue; Michelle Connole; Mark A Exley; Amitinder Kaur
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

Review 8.  Innate immunity against HIV: a priority target for HIV prevention research.

Authors:  Persephone Borrow; Robin J Shattock; Annapurna Vyakarnam
Journal:  Retrovirology       Date:  2010-10-11       Impact factor: 4.602

Review 9.  HIV-1 Vpu interference with innate cell-mediated immune mechanisms.

Authors:  Johan K Sandberg; Sofia K Andersson; Susanna M Bächle; Douglas F Nixon; Markus Moll
Journal:  Curr HIV Res       Date:  2012-06       Impact factor: 1.581

10.  Peripheral blood invariant natural killer T cells of pig-tailed macaques.

Authors:  Xiangming Li; Patricia Polacino; Raquel Garcia-Navarro; Shiu-Lok Hu; Moriya Tsuji
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.